Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PPP2CB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARMC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
POLR1D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC400027 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
AURKAIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDRG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP4S1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMACR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDKN1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP2R2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGPEP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRPF31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMA7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRSAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on